Langie, S.A.S. (Sabine A. S.)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
3 results
Search Results
Now showing 1 - 3 of 3
- Potassium bromate as positive assay control for the Fpg-modified comet assay(Oxford University Press, 2020) Stopper, H. (Helga); Langie, S.A.S. (Sabine A. S.); Scavone, F. (Francesca); Bankoglu, E.E. (Ezgi Eyluel); Kruszewski, M. (Marcin); Wojewódzka, M. (Maria); Jensen, A. (Annie); Marino, M. (Mirko); Richling, E. (Elke); Bakuradze, T. (Tamara); Muruzábal, D. (Damián); Riso, P. (Patrizia); Del-Bo, C. (Cristian); Möller, P. (Peter); Shaposhnikov, S. (Sergey); Costa, S. (Solange); Teixeira, J.P. (Joao Paulo); Laffon, B. (Blanca); Giovannelli, L. (Lisa); Costa, C. (Carlos); Azqueta, A. (Amaya); Valdiglesias, V. (Vanessa); Collins, A. (A.)The comet assay is a popular assay in biomonitoring studies. DNA strand breaks (or unspecific DNA lesions) are measured using the standard comet assay. Oxidative stress-generated DNA lesions can be measured by employing DNA repair enzymes to recognise oxidatively damaged DNA. Unfortunately, there has been a tendency to fail to report results from assay controls (or maybe even not to employ assay controls). We believe this might have been due to uncertainty as to what really constitutes a positive control. It should go without saying that a biomonitoring study cannot have a positive control group as it is unethical to expose healthy humans to DNA damaging (and thus potentially carcinogenic) agents. However, it is possible to include assay controls in the analysis (here meant as a cryopreserved sample of cells i.e. included in each experiment as a reference sample). In the present report we tested potassium bromate (KBrO3) as a positive comet assay control for the formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay. Ten laboratories used the same procedure for treatment of monocytic THP-1 cells with KBrO3 (0.5, 1.5 and 4.5 mM for 1 h at 37°C) and subsequent cryopreservation. Results from one laboratory were excluded in the statistical analysis because of technical issues in the Fpg-modified comet assay. All other laboratories found a concentration–response relationship in cryopreserved samples (regression coefficients from 0.80 to 0.98), although with different slopes ranging from 1.25 to 11.9 Fpg-sensitive sites (%DNA in tail) per 1 mM KBrO3. Our results demonstrate that KBrO3 is a suitable positive comet assay control.
- Further development of CometChip technology to measure DNA damage in vitro and in vivo: Comparison with the 2 gels/slide format of the standard and enzyme-modified comet assay(Elsevier, 2024) Langie, S.A.S. (Sabine A. S.); Collia, M. (Miguel); Vettorazzi, A. (Ariane); Møller, P. (Peter); Azqueta, A. (Amaya)DNA damage plays a pivotal role in carcinogenesis and other diseases. The comet assay has been used for more than three decades to measure DNA damages. The 1-2 gels/slide format is the most used version of the assay. In 2010, a high throughput 96 macrowell format with a spatially encoded array of microwells patterned in agarose was developed, called the CometChip. The commercial version (CometChip®) has been used for the in vitro standard version of the comet assay (following the manufacturer's protocol), although it has not been compared directly with the 2 gels/slide format. The aim of this work is to developed new protocols to allow use of DNA repair enzymes as well as the analysis of in vivo frozen tissue samples in the CometChip®, to increase the throughput, and to compare its performance with the classic 2 gels/slide format. We adapted the manufacturer's protocol to allow the use of snap frozen tissue samples, using male Wistar rats orally dosed with methyl methanesulfonate (MMS, 200 mg/kg b.w.), and to detect altered nucleobases using DNA repair enzymes, with TK6 cells treated with potassium bromate (KBrO3, 0-4 mM, 3 h) and formamidopyrimidine DNA glycosylase (Fpg) as the enzyme. Regarding the standard version of the comet, we performed thee comparison of the 2 gel/slide and CometChip® format (using the the manufacturer's protocol), using TK6 cells with MMS (100-800 µM, 1 h) and hydrogen peroxide (H2O2, 7.7-122.5 µM, 5 min) as testing compounds. In all cases the CometChip® was performed along with the 2 gels/slide format. Results obtained were comparable and the CometChip® is a good alternative to the 2 gels/slide format when a higher throughput is required.
- Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results(2020) Stopper, H. (Helga); Boutet-Robinet, E. (Elisa); Langie, S.A.S. (Sabine A. S.); Collins, A. (Andrew); Cooke, M.S. (Marcus S.); Sramkova, M. (Monika); Richling, E. (Elke); Moraes-de-Andrade, V. (Vanessa); Novak, M. (Matjaz); Del-Bo, C. (Cristian); Koppen, G. (Gudrun); Godschalk, R. (Roger); Bonassi, S. (Stefano); Costa, S. (Solange); Teixeira, J.P. (Joao Paulo); Gützkow, K.B. (Kristine Bjerve); Gajski, G. (Goran); Costa-Pereira, C. (Cristiana); Møller, P. (Peter); Dusinska, M. (Maria); Laffon, B. (Blanca); Milic, M. (Mirta); Giovannelli, L. (Lisa); Vodicka, P. (Pavel); Zegura, B. (Bojana); Vodenkova, S. (Sona); Azqueta, A. (Amaya); Brunborg, G. (Gunnar); Valdiglesias, V. (Vanessa); Gabelova, A. (Alena); Basaran, N. (Nursen)The comet assay is a widely used test for the detection of DNA damage and repair activity. However, there are interlaboratory differences in reported levels of baseline and induced damage in the same experimental systems. These differences may be attributed to protocol differences, although it is difficult to identify the relevant conditions because detailed comet assay procedures are not always published. Here, we present a Consensus Statement for the Minimum Information for Reporting Comet Assay (MIRCA) providing recommendations for describing comet assay conditions and results. These recommendations differentiate between ‘desirable’ and ‘essential’ information: ‘essential’ information refers to the precise details that are necessary to assess the quality of the experimental work, whereas ‘desirable’ information relates to technical issues that might be encountered when repeating the experiments. Adherence to MIRCA recommendations should ensure that comet assay results can be easily interpreted and independently verified by other researchers.